基于GEO数据库与R语言的喉鳞状细胞癌分子特征分析
Analysis of Molecular Characterization of Laryngeal Squamous Cell Carcinoma Based on GEO Datasets and R Language
摘要: 目的:基于GEO数据库与R语言生物信息学方法,对公开LSCC表达谱数据集GSE59102进行再分析,系统刻画其差异表达基因、GO功能和KEGG通路富集特征,并从细胞周期、细胞外基质重塑和炎症微环境等角度归纳该数据集中LSCC的主要分子改变,为后续可验证的机制研究提供线索。方法:从GEO数据库下载LSCC表达谱数据集GSE59102作为主要分析队列,GSE10288作为辅助验证队列。采用R语言对表达矩阵进行预处理、标准化和差异表达分析,以adjusted P value < 0.05且|log2FC| > 1为筛选标准获得差异表达基因(DEGs),并绘制火山图和热图。随后利用cluster Profiler包进行Gene Ontology (GO)和Kyoto Encyclopedia of Genes and Genomes (KEGG)富集分析,并结合既往文献对主要差异基因及其可能涉及的生物学过程进行讨论。结果:GSE59102共纳入29例肿瘤样本和13例正常/安全边界样本。按照上述阈值共筛选出3439个显著差异表达基因,包括1526个上调基因和1913个下调基因。上调基因中MMP12、HOXC13、LINC01980、CDC6、CASC9、HOXC13-AS、FGD6和MCM2等变化较为明显;下调基因主要包括PLP1、CRISP2、NUCB2、VSX1、CAB39L、CRISP3和EHF等。前50个差异基因的热图能够较好地区分肿瘤组和正常组。GO富集结果主要涉及nuclear division、chromosome segregation、extracellular matrix、basement membrane、integrin binding及cytokine activity等条目;KEGG富集主要涉及Cell cycle、DNA replication、Cytokine-cytokine receptor interaction和Complement and coagulation cascades等通路。由于GSE10288平台覆盖基因较少,两个队列共同且同向变化的基因数量有限,未进一步开展稳定性不足的联合富集分析。结论:基于GSE59102数据集的分析结果提示,LSCC组织的转录组异常主要表现为细胞周期激活、细胞外基质重塑及炎症/细胞因子信号改变。MMP12、HOXC13、CASC9、CDC6和MCM2等基因可作为后续实验验证的候选分子。由于外部验证受平台覆盖范围限制,本文结果仍主要反映单一公开数据集中的分子特征,其稳定性和普适性有待更多独立队列及实验研究进一步确认。
Abstract: Objective: To reanalyze the public LSCC expression dataset GSE59102 using GEO data and R-based bioinformatics methods, to systematically characterize differentially expressed genes and their GO/KEGG enrichment patterns, and to summarize the major molecular features of LSCC in this dataset from the perspectives of cell-cycle regulation, extracellular matrix remodeling and inflammatory microenvironment, providing clues for subsequent verifiable mechanistic studies. Methods: The LSCC expression profile dataset GSE59102 was downloaded from the GEO database as the main discovery cohort, and GSE10288 was used as an auxiliary validation cohort. R was employed to perform preprocessing, normalization, and differential expression analysis of the expression matrix. Differentially Expressed Genes (DEGs) were identified using adjusted P value < 0.05 and |log2FC| > 1 as the threshold, and volcano plots and heatmaps were generated. Subsequently, the cluster Profiler package was used to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. The representative differentially expressed genes and their potential biological processes were then discussed in the context of published studies. Results: In GSE59102, 29 tumor samples and 13 normal/safety-margin samples were included. A total of 3439 significant DEGs were identified, including 1526 upregulated genes and 1913 downregulated genes. MMP12, HOXC13, LINC01980, CDC6, CASC9, HOXC13-AS, FGD6 and MCM2 were among the representative upregulated genes, whereas PLP1, CRISP2, NUCB2, VSX1, CAB39L, CRISP3 and EHF were among the downregulated genes. The heatmap of the top 50 differentially expressed genes effectively distinguished the tumor group from the normal group. Go enrichment results primarily involved terms such as nuclear division, chromosome segregation, extracellular matrix, basement membrane, integrin binding and cytokine activity; KEGG enrichment primarily involved pathways such as Cell cycle, DNA replication, Cytokine-cytokine receptor interaction and Complement and coagulation cascades. Because of the limited gene coverage of GSE10288, the number of genes that were commonly and unidirectionally altered across the two cohorts was limited, no further joint enrichment analysis was conducted due to insufficient stability. Conclusion: The analysis based on GSE59102 suggests that LSCC tissues are characterized by abnormal activation of cell-cycle programs, extracellular matrix remodeling and inflammatory/cytokine signaling. MMP12, HOXC13, CASC9, CDC6 and MCM2 may be considered candidate molecules for further experimental validation. Because external validation was limited by platform gene coverage, the present findings should be interpreted as molecular features observed in a specific public dataset, and their stability and generalizability require confirmation in additional independent cohorts and experimental models.
文章引用:王斌, 胡煜. 基于GEO数据库与R语言的喉鳞状细胞癌分子特征分析[J]. 临床医学进展, 2026, 16(6): 2023-2034. https://doi.org/10.12677/acm.2026.1662422

参考文献

[1] Johnson, D.E., Burtness, B., Leemans, C.R., Lui, V.W.Y., Bauman, J.E. and Grandis, J.R. (2020) Head and Neck Squamous Cell Carcinoma. Nature Reviews Disease Primers, 6, Article No. 92. [Google Scholar] [CrossRef] [PubMed]
[2] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[3] Cavaliere, M., Bisogno, A., Scarpa, A., D’Urso, A., Marra, P., Colacurcio, V., et al. (2021) Biomarkers of Laryngeal Squamous Cell Carcinoma: A Review. Annals of Diagnostic Pathology, 54, Article ID: 151787. [Google Scholar] [CrossRef] [PubMed]
[4] Verro, B., Saraniti, C., Carlisi, D., Chiesa-Estomba, C., Maniaci, A., Lechien, J.R., et al. (2023) Biomarkers in Laryngeal Squamous Cell Carcinoma: The Literature Review. Cancers, 15, Article 5096. [Google Scholar] [CrossRef] [PubMed]
[5] Falco, M., Tammaro, C., Takeuchi, T., Cossu, A.M., Scafuro, G., Zappavigna, S., et al. (2022) Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. Cancers, 14, Article 1716. [Google Scholar] [CrossRef] [PubMed]
[6] Guo, F., Li, S., Yan, S., Zhang, Y., Wang, G. and Ma, R. (2025) Bioinformatics Analysis of Laryngeal Squamous Cell Carcinoma Based on the High Infection Rate of HPV in Northwest China. PeerJ, 13, e19851. [Google Scholar] [CrossRef] [PubMed]
[7] Maniaci, A., Giurdanella, G., Chiesa Estomba, C., Mauramati, S., Bertolin, A., Lionello, M., et al. (2024) Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer. Journal of Personalized Medicine, 14, Article 1048. [Google Scholar] [CrossRef] [PubMed]
[8] Hsia, B., Bitar, G.A., Tran, N.S., Keenehan, K., Bonilla, P.S., Alshaka, S., et al. (2025) Genomic Profiling of Laryngeal Squamous Cell Carcinoma Reveals Novel Biomarkers for Precision Medicine. Journal of Personalized Medicine, 16, Article 2. [Google Scholar] [CrossRef
[9] Chen, Q., Wang, D., Chen, Z., Lin, L., Shao, Q., Zhang, H., et al. (2024) Predicting Biomarkers in Laryngeal Squamous Cell Carcinoma Based on the Cytokine-Cytokine Receptor Interaction Pathway. Heliyon, 10, e37738. [Google Scholar] [CrossRef] [PubMed]
[10] Zhang, P., Chen, W., Chen, K., Ye, Y. and Wu, W. (2025) Identification of Biomarkers for Laryngeal Squamous Cell Carcinoma through Mendelian Randomization and Integrated Bioinformatics Analysis. Discover Oncology, 16, Article No. 1364. [Google Scholar] [CrossRef] [PubMed]
[11] Curado, M.P. and Hashibe, M. (2009) Recent Changes in the Epidemiology of Head and Neck Cancer. Current Opinion in Oncology, 21, 194-200. [Google Scholar] [CrossRef] [PubMed]
[12] Wyss, A., Hashibe, M., Chuang, S., Lee, Y.A., Zhang, Z., Yu, G., et al. (2013) Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium. American Journal of Epidemiology, 178, 679-690. [Google Scholar] [CrossRef] [PubMed]
[13] Peterson, L.A., Bellile, E.L., Wolf, G.T., Virani, S., Shuman, A.G., Taylor, J.M.G., et al. (2016) Cigarette Use, Comorbidities, and Prognosis in a Prospective Head and Neck Squamous Cell Carcinoma Population. Head & Neck, 38, 1810-1820. [Google Scholar] [CrossRef] [PubMed]
[14] Colombo, J., Fachel, A.A., De Freitas Calmon, M., et al. (2009) Gene Expression Profiling Reveals Molecular Marker Candidates of Laryngeal Squamous Cell Carcinoma. Oncology Reports, 21, 649-663.
[15] Liu, F., Du, J., Liu, J. and Wen, B. (2016) Identification of Key Target Genes and Pathways in Laryngeal Carcinoma. Oncology Letters, 12, 1279-1286. [Google Scholar] [CrossRef] [PubMed]
[16] Ma, L., Li, W., Zhang, X., Huang, D., Zhang, H., Xiao, J., et al. (2009) Differential Gene Expression Profiling of Laryngeal Squamous Cell Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays. Archives of Medical Research, 40, 114-123. [Google Scholar] [CrossRef] [PubMed]
[17] Saloura, V., Vougiouklakis, T., Zewde, M., Kiyotani, K., Park, J., Gao, G., et al. (2016) WHSC1L1 Drives Cell Cycle Progression through Transcriptional Regulation of CDC6 and CDK2 in Squamous Cell Carcinoma of the Head and Neck. Oncotarget, 7, 42527-42538. [Google Scholar] [CrossRef] [PubMed]
[18] Vivatvakin, S., Ratchataswan, T., Leesutipornchai, T., Ruangritchankul, K., Keelawat, S., Mahattanasakul, P., et al. (2021) MCM-2, Ki-67, and EGFR Downregulated Expression Levels in Advanced Stage Laryngeal Squamous Cell Carcinoma. Scientific Reports, 11, Article No. 14607. [Google Scholar] [CrossRef] [PubMed]
[19] Saint, A. and Van Obberghen-Schilling, E. (2021) The Role of the Tumor Matrix Environment in Progression of Head and Neck Cancer. Current Opinion in Oncology, 33, 168-174. [Google Scholar] [CrossRef] [PubMed]
[20] Goh, K.Y., Lau, K.W., Cheng, T.Y.D., Tham, S.C., Lim, C.T., Iyer, N.G., et al. (2022) Matrisomal Genes in Squamous Cell Carcinoma of Head and Neck Influence Tumor Cell Motility and Response to Cetuximab Treatment. Cancer Communications, 42, 355-359. [Google Scholar] [CrossRef] [PubMed]
[21] Hu, C., Zhang, Y., Wu, C. and Huang, Q. (2023) Heterogeneity of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma: Opportunities and Challenges. Cell Death Discovery, 9, Article No. 124. [Google Scholar] [CrossRef] [PubMed]
[22] Saleem, Z., Shaikh, A.H., Zaman, U., Ahmed, S., Majeed, M.M., Kazmi, A., et al. (2021) Estimation of Salivary Matrix Metalloproteinases-12 (MMP-12) Levels among Patients Presenting with Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma. BMC Oral Health, 21, Article No. 205. [Google Scholar] [CrossRef] [PubMed]
[23] Chen, X., Lei, H., Cheng, Y.X., et al. (2024) CXCL8, MMP12, and MMP13 Are Common Biomarkers of Periodontitis and Oral Squamous Cell Carcinoma. Oral Diseases, 30, 390-407.
[24] de Barros e Lima Bueno, R., Ramão, A., Pinheiro, D.G., Alves, C.P., Kannen, V., Jungbluth, A.A., et al. (2016) HOX Genes: Potential Candidates for the Progression of Laryngeal Squamous Cell Carcinoma. Tumor Biology, 37, 15087-15096. [Google Scholar] [CrossRef] [PubMed]
[25] He, S., He, Y., Zhu, S., Wang, R., Liu, S., Wang, L., et al. (2024) M2 Macrophage Exosomal HOXC13-AS in Laryngeal Cancer Immunity via Targeting miR-485-5p/IGF2BP2/PD-L1. International Immunopharmacology, 140, Article ID: 112742. [Google Scholar] [CrossRef] [PubMed]
[26] Xiong, D., Wu, W., Kan, L., Chen, D., Dou, X., Ji, X., et al. (2020) LINC00958 and HOXC13-AS as Key Candidate Biomarkers in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis. PeerJ, 8, e8557. [Google Scholar] [CrossRef] [PubMed]
[27] Sassenberg, M., Droop, J., Schulz, W.A., Dietrich, D., Loick, S.M., Wiek, C., et al. (2019) Upregulation of the Long Non-Coding RNA CASC9 as a Biomarker for Squamous Cell Carcinoma. BMC Cancer, 19, Article No. 806. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, Y., Chen, D., Liu, H. and Yang, K. (2019) Increased Expression of LncRNA CASC9 Promotes Tumor Progression by Suppressing Autophagy-Mediated Cell Apoptosis via the Akt/mTOR Pathway in Oral Squamous Cell Carcinoma. Cell Death & Disease, 10, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[29] Denaro, N., Solinas, C., Garrone, O., Cauchi, C., Ruatta, F., Wekking, D., et al. (2022) The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience. Diagnostics, 12, Article 2880. [Google Scholar] [CrossRef] [PubMed]
[30] Nisar, S., Yousuf, P., Masoodi, T., Wani, N.A., Hashem, S., Singh, M., et al. (2022) Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. International Journal of Molecular Sciences, 22, Article 4584. [Google Scholar] [CrossRef] [PubMed]
[31] Tan, C.T., Chu, C.Y., Lu, Y.C., Chang, C.C., Lin, B.R., Wu, H.H., et al. (2008) CXCL12/CXCR4 Promotes Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Metastasis through MMP-13-Dependent Invasion via the ERK1/2/AP-1 Pathway. Carcinogenesis, 29, 1519-1527. [Google Scholar] [CrossRef] [PubMed]